Journal article

Antibody landscapes after influenza virus infection or vaccination

JM Fonville, SH Wilks, SL James, A Fox, M Ventresca, M Aban, L Xue, TC Jones, NMH Le, QT Pham, ND Tran, Y Wong, A Mosterin, LC Katzelnick, D Labonte, TT Le, G van der Net, E Skepner, CA Russell, TD Kaplan Show all

Science | AMER ASSOC ADVANCEMENT SCIENCE | Published : 2014

Grants

Awarded by Medical Research Council Fellowship


Awarded by Royal Society University Research Fellowship


Awarded by National Institute of Allergy and Infectious Diseases-NIH Centers of Excellence for Influenza Research and Surveillance contracts


Awarded by Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant


Awarded by European Union


Awarded by Human Frontier Science Program grant


Awarded by Wellcome Trust


Awarded by NIH Director's Pioneer Award


Awarded by Medical Research Council


Awarded by OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH


Funding Acknowledgements

We thank R. Bodewes, J. Bryant, D. Burke, N. Lewis, E. Selkov, B. Muhlemann, G. de Mutsert, and F. Pistoor. We also thank the staff of the Ha Nam Provincial Preventive Medicine Centre, the Hamlet health workers, and the National Institute for Hygiene and Epidemiology, Vietnam, for their support in conducting the fieldwork. We are indebted to the cooperation of the Ha Nam cohort and vaccine study participants. J.M.F. is supported by a Medical Research Council Fellowship (MR/K021885/1) and a Junior Research Fellowship from Homerton College, L. C. K. by the Gates-Cambridge Scholarship and the NIH Oxford-Cambridge Scholars program, and C. A. R. by a Royal Society University Research Fellowship (RG55423). We acknowledge the National Institute of Allergy and Infectious Diseases-NIH Centers of Excellence for Influenza Research and Surveillance contracts HHSN266200700010C and HHSN272201400008C, Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant 91896613, the European Union FP7 programs EMPERIE (223498) and ANTIGONE (278976), Human Frontier Science Program grant P0050/2008, the Wellcome Trust (WT087982MA), and NIH Director's Pioneer Award DP1-OD000490-01. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian government Department of Health. A.D.M.E.O. (as Chief Scientific Officer of Viroclinics Biosciences BV) has advisory affiliations with GlaxoSmithKline, Novartis, and Roche. Sequences of the influenza viruses used in this study are available in GenBank with accession numbers: KM821278 to KM821358. Erasmus Medical Center (Rotterdam, the Netherlands) requires a materials transfer agreement for sharing viruses and antisera.